Volume XXII NO. 9 – June 22, 2015
In this issue:
MEDICARE AND ITS STATE ANCILLARIES are poised to make deep cuts to lab test prices, starting with Medi-Cal in California. The state legislature there approved cuts of 25-30% which went into effect July 1, 2015. And Medicare officials, along with Congress, have embarked on a comparable effort to lower Medicare Part B clinical lab test fees to the similar levels that the two blood brothers give to their preferred customers. In addition, Medicare has now decided to end coverage for many pharmacogenomic tests, putting at risk as many as 19 million Americans who have genetic variations affecting their response to medications.